Latest Updates Around The World
Shares of Corona Remedies and Wakefit Innovations are set to debut on the stock exchanges on Monday, with gray market signals pointing to a positive start for both companies, albeit with different levels of investor confidence.Corona Remedies, the bigger of the two in terms of market buzz, has a GMP of around 28%, indicating expectations […]
India’s primary market pipeline remains active in the third week of December, with four public issues with a combined value of around Rs 830 crore set to open next week, led by a motherboard offering from KSH International. In addition, investors’ focus will also continue to be on a busy listing calendar, with as many […]
ET Intelligence Group: Corona Remedies, a pharmaceutical company, plans to raise Rs 655.4 crore through an offer for sale. The promoter group’s stake will drop from 72.5% to 69% after the IPO. The company focuses on the specialist doctors, which is driving revenue growth faster than the Indian pharmaceutical market (IPM). Specialists accounted for 75.8% […]
Next week will see one of the busiest times of the year for India’s primary market, with 11 subscription IPOs in the motherboard and SMB segments. Together, the issuances scheduled for December 8 to 17 will raise about Rs 13,807 crore, including the much-awaited IPO of ICICI Prudential Asset Management, the dates of which are […]
Pharmaceutical company Corona Remedies, which is backed by private equity firm ChrysCapital, on Wednesday set a price range of Rs 1,008-1,062 per share for its upcoming initial public offering (IPO), valuing the company at nearly Rs 6,500 crore. The initial public offer of Rs 655.37 crore, which is entirely an Offer For Sale (OFS) by […]
